Advances in Cancer Research, Volume 138, the latest release in this ongoing, well-regarded serial provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents original reviews on research bridging oncology and gene expression, with this volume covering unconventional approaches to modulating the immunogenicity of tumor cells, tumor dormancy and immunoediting, the emerging role of anti-apoptotic Bcl-2 family proteins in chemoresistance, Beclin-1 and autophagy, MDA-7/IL-24, and nanotechnology and medicine.
1. Cover image - p. page_iv 2. Title page - p. page_iv 3. Table of Contents - p. page_iv 4. Copyright - p. page_iv 5. Contributors - p. page_ix 6. Chapter One: Leveraging Epigenetics to Enhance the Cellular Response to Chemotherapies and Improve Tumor Immunogenicity - p. page_x 7. Chapter Two: VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation - p. page_39 8. Chapter Three: Acquired Resistance to Drugs Targeting Tyrosine Kinases - p. page_69 9. Chapter Four: Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes - p. page_98 10. Chapter Five: Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases - p. page_142 11. Chapter Six: Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics - p. page_182 12. Chapter Seven: Prospects of Gene Therapy to Treat Melanoma - p. page_211
Advances in Cancer Research, Volume 138, the latest release in this ongoing, well-regarded serial provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents original reviews on research bridging oncology and gene expression, with this volume covering unconventional approaches to modulating the immunogenicity of tumor cells, tumor dormancy and immunoediting, the emerging role of anti-apoptotic Bcl-2 family proteins in chemoresistance, Beclin-1 and autophagy, MDA-7/IL-24, and nanotechnology and medicine.
1. Cover image - p. page_iv 2. Title page - p. page_iv 3. Table of Contents - p. page_iv 4. Copyright - p. page_iv 5. Contributors - p. page_ix 6. Chapter One: Leveraging Epigenetics to Enhance the Cellular Response to Chemotherapies and Improve Tumor Immunogenicity - p. page_x 7. Chapter Two: VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation - p. page_39 8. Chapter Three: Acquired Resistance to Drugs Targeting Tyrosine Kinases - p. page_69 9. Chapter Four: Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes - p. page_98 10. Chapter Five: Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases - p. page_142 11. Chapter Six: Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics - p. page_182 12. Chapter Seven: Prospects of Gene Therapy to Treat Melanoma - p. page_211
